Abstract
CC chemokine receptor (CCR) 8, which is expressed on Th2 cells and eosinophils, has been implicated in allergic diseases. This review represents an overview of the functional roles of CCR8 in the pathogenesis of eosinophilic inflammation and debates the potential of recently developed CCR8 antagonists to treat allergic disorders.
Keywords: Allergy, atopic dermatitis, bronchial asthma, chemokine, eosinophil, knockout mouse, Th2 cell
Mini-Reviews in Medicinal Chemistry
Title: Functional Chemokine Receptors in Allergic Diseases: Is CCR8 a Novel Therapeutic Target?
Volume: 6 Issue: 4
Author(s): E. Mitsuyama, Y. Kunori, T. Kamimura and O. Kaminuma
Affiliation:
Keywords: Allergy, atopic dermatitis, bronchial asthma, chemokine, eosinophil, knockout mouse, Th2 cell
Abstract: CC chemokine receptor (CCR) 8, which is expressed on Th2 cells and eosinophils, has been implicated in allergic diseases. This review represents an overview of the functional roles of CCR8 in the pathogenesis of eosinophilic inflammation and debates the potential of recently developed CCR8 antagonists to treat allergic disorders.
Export Options
About this article
Cite this article as:
Mitsuyama E., Kunori Y., Kamimura T. and Kaminuma O., Functional Chemokine Receptors in Allergic Diseases: Is CCR8 a Novel Therapeutic Target?, Mini-Reviews in Medicinal Chemistry 2006; 6 (4) . https://dx.doi.org/10.2174/138955706776361394
DOI https://dx.doi.org/10.2174/138955706776361394 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Update on D-Ala-Peptide T-Amide (DAPTA): A Viral Entry Inhibitor that Blocks CCR5 Chemokine Receptors
Current HIV Research Immunopotentiation for Bacterial Biodefense
Current Topics in Medicinal Chemistry Endocrine Orchestration of Cardiovascular, Gastrointestinal and Hypothalamic Control
Current Medicinal Chemistry Tumor Necrosis Factor Blockade for Treatment of Inflammatory Bowel Disease: Efficacy and Safety
Current Molecular Pharmacology Enzyme Mediated Baeyer-Villiger Oxidations
Current Organic Chemistry Activation and Regulation of Toll-like Receptor 9: CpGs and Beyond
Mini-Reviews in Medicinal Chemistry Nocistatin: Milestone of One Decade of Research
Current Pharmaceutical Design Recent Advances in Thermosensitive Hydrogels as Drug Delivery Systems: A Review
Drug Delivery Letters ADAMTS Proteinases: Potential Therapeutic Targets?
Current Pharmaceutical Biotechnology The Use of Vitamin D in Respiratory Diseases
Current Respiratory Medicine Reviews Vitiligo in Children: A Birds Eye View
Current Pediatric Reviews Pediatric Oral Lichen Planus: Review and Case Report
Current Pediatric Reviews Conditional Reprogramming Inducing Clinical Cells Proliferation: New Research Tools in Tumor and Inflammatory-related Diseases
Current Pharmaceutical Design The Molecular Functions of Nod Proteins and their Associated Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Does Global Gene Expression Analysis in Type 2 Diabetes Provide an Opportunity to Identify Highly Promising Drug Targets?
Endocrine, Metabolic & Immune Disorders - Drug Targets Meet Our Editorial Board Member
Current Cancer Drug Targets Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: 'A Hard Days Night'
Current Pharmaceutical Design Differences in Serum Biomarkers Between Combined Glucosamine and Chondroitin Versus Celecoxib in a Randomized, Double-blind Trial in Osteoarthritis Patients
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Synthesis, Molecular Docking Study, and Cytotoxic Activity of 1,3,5-triaryl Pyrazole Derivatives
Letters in Drug Design & Discovery Erlotinib: A Targeted Anticancer Drug
Current Cancer Therapy Reviews